Cargando…
Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
BACKGROUND: Hyperprolactinemia is a common adverse reaction in patients with schizophrenia who take antipsychotic drugs; it often leads to treatment non-compliance in patients and has an adverse effect on their prognosis. AIMS: This study aimed to explore the risk factors of elevated prolactin (PRL)...
Autores principales: | He, Sidi, Yu, Wen Juan, Wang, Xiaoliang, Zhang, Lei, Zhao, Nan, Li, Guanjun, Shen, Yi Feng, Li, Huafang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342815/ https://www.ncbi.nlm.nih.gov/pubmed/32695960 http://dx.doi.org/10.1136/gpsych-2020-100206 |
Ejemplares similares
-
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015) -
Olanzapine-Induced Hyperprolactinemia: Two Case Reports
por: Barata, Pedro Cabral, et al.
Publicado: (2019) -
Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
por: Bise, S., et al.
Publicado: (2022) -
Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia
por: Lin, Chih-Hsun, et al.
Publicado: (2012) -
Risperidone Induced Hyperprolactinemia: From Basic to Clinical Studies
por: Stojkovic, Milena, et al.
Publicado: (2022)